Therefore, we believed CCNE1, TTK and EXO1 were remarkably overexpressed in BC tissues compared with para-carcinoma tissue, and might be promising to screen BC and further distinguish the high risks of BRCA1/2 mutations from wild-type BC, while ignoring the potential impact of the genetic background related to the race itself to some extent. This evidence concerns the gene BRCA1 and carcinoma.